CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - EUR (€) € in Thousands, shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenues
Research and development services	€ 0	€ 3
Sales other	3	0
Grants	1,025	427
Total Revenues	1,028	430
Expenses
Research and development	1,442	975
General and administrative	1,331	1,105
Total Expenses	2,773	2,080
Operating Loss	(1,745)	(1,650)
Interest expense	2,800	2,751
Other (income) expense	260	329
Loss before income tax provision	(4,805)	(4,730)
Income tax provision	0	0
Net loss	(4,805)	(4,730)
Other comprehensive loss
Foreign currency translation adjustment	(5)	(4)
Comprehensive loss	€ (4,810)	€ (4,734)
Basic and diluted loss per share	€ (0.02)	€ (0.02)
Weighted average number of shares used in per share calculations	303,757,622	303,757,622